Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Non-cash Items: 2012-2022

Historic Non-cash Items for Ani Pharmaceuticals (ANIP) over the last 7 years, with Dec 2022 value amounting to $686,000.

  • Ani Pharmaceuticals' Non-cash Items fell 89.89% to $686,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $686,000, marking a year-over-year decrease of 89.89%. This contributed to the annual value of $686,000 for FY2022, which is 11.91% up from last year.
  • According to the latest figures from FY2022, Ani Pharmaceuticals' Non-cash Items is $686,000, which was up 11.91% from $613,000 recorded in FY2021.
  • Ani Pharmaceuticals' 5-year Non-cash Items high stood at $2.2 million for FY2018, and its period low was $366,000 during FY2019.
  • In the last 3 years, Ani Pharmaceuticals' Non-cash Items had a median value of $613,000 in 2021 and averaged $557,000.
  • Its Non-cash Items has fluctuated over the past 5 years, first crashed by 86.77% in 2018, then spiked by 64.78% in 2021.
  • Yearly analysis of 5 years shows Ani Pharmaceuticals' Non-cash Items stood at $2.2 million in 2018, then tumbled by 83.52% to $366,000 in 2019, then climbed by 1.64% to $372,000 in 2020, then spiked by 64.78% to $613,000 in 2021, then increased by 11.91% to $686,000 in 2022.